Compare Pfizer with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ALEMBIC PHARMA - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER ALEMBIC PHARMA PFIZER/
ALEMBIC PHARMA
 
P/E (TTM) x 48.9 16.6 295.0% View Chart
P/BV x 8.1 6.6 123.2% View Chart
Dividend Yield % 0.4 0.6 72.7%  

Financials

 PFIZER   ALEMBIC PHARMA
EQUITY SHARE DATA
    PFIZER
Mar-19
ALEMBIC PHARMA
Mar-19
PFIZER/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs3,840664 578.3%   
Low Rs2,080412 504.4%   
Sales per share (Unadj.) Rs455.0208.7 218.0%  
Earnings per share (Unadj.) Rs93.831.0 302.5%  
Cash flow per share (Unadj.) Rs109.437.1 294.8%  
Dividends per share (Unadj.) Rs22.505.50 409.1%  
Dividend yield (eoy) %0.81.0 74.4%  
Book value per share (Unadj.) Rs658.2144.2 456.4%  
Shares outstanding (eoy) m45.75188.52 24.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.52.6 252.3%   
Avg P/E ratio x31.617.4 181.8%  
P/CF ratio (eoy) x27.114.5 186.6%  
Price / Book Value ratio x4.53.7 120.5%  
Dividend payout %24.017.7 135.2%   
Avg Mkt Cap Rs m135,420101,461 133.5%   
No. of employees `0002.6NA-   
Total wages/salary Rs m3,2387,467 43.4%   
Avg. sales/employee Rs Th7,911.4NM-  
Avg. wages/employee Rs Th1,230.9NM-  
Avg. net profit/employee Rs Th1,630.7NM-  
INCOME DATA
Net Sales Rs m20,81539,347 52.9%  
Other income Rs m1,67494 1,784.5%   
Total revenues Rs m22,48939,441 57.0%   
Gross profit Rs m5,7128,736 65.4%  
Depreciation Rs m7141,152 62.0%   
Interest Rs m73184 39.6%   
Profit before tax Rs m6,5997,493 88.1%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-93 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,3091,568 147.3%   
Profit after tax Rs m4,2915,844 73.4%  
Gross profit margin %27.422.2 123.6%  
Effective tax rate %35.020.9 167.2%   
Net profit margin %20.614.9 138.8%  
BALANCE SHEET DATA
Current assets Rs m27,16719,577 138.8%   
Current liabilities Rs m8,91714,896 59.9%   
Net working cap to sales %87.711.9 737.0%  
Current ratio x3.01.3 231.8%  
Inventory Days Days6890 75.6%  
Debtors Days Days3045 66.4%  
Net fixed assets Rs m8,86227,097 32.7%   
Share capital Rs m458377 121.4%   
"Free" reserves Rs m29,65626,811 110.6%   
Net worth Rs m30,11327,188 110.8%   
Long term debt Rs m254,993 0.5%   
Total assets Rs m39,40047,778 82.5%  
Interest coverage x91.541.7 219.5%   
Debt to equity ratio x00.2 0.5%  
Sales to assets ratio x0.50.8 64.1%   
Return on assets %11.112.6 87.8%  
Return on equity %14.221.5 66.3%  
Return on capital %22.123.6 93.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m42819,453 2.2%   
Fx outflow Rs m7866,065 13.0%   
Net fx Rs m-35813,388 -2.7%   
CASH FLOW
From Operations Rs m9788,120 12.0%  
From Investments Rs m351-7,556 -4.6%  
From Financial Activity Rs m-1,099590 -186.1%  
Net Cashflow Rs m2311,153 20.0%  

Share Holding

Indian Promoters % 0.0 74.1 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 2.9 258.6%  
FIIs % 4.9 9.1 53.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 13.9 170.5%  
Shareholders   85,207 49,328 172.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   TORRENT PHARMA  NATCO PHARMA  ELDER PHARMA  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  

Compare PFIZER With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Falls 471 Points, Nifty Ends Below 14,700; Tata Steel & JSW Steel Top Losers(Closing)

Indian share markets witnessed selling pressure throughout the day today and ended lower.

Related Views on News

PFIZER Announces Quarterly Results (3QFY21); Net Profit Up 1.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, PFIZER has posted a net profit of Rs 1 bn (up 1.6% YoY). Sales on the other hand came in at Rs 6 bn (up 10.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

PFIZER Announces Quarterly Results (2QFY21); Net Profit Down 14.8% (Quarterly Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

For the quarter ended September 2020, PFIZER has posted a net profit of Rs 1 bn (down 14.8% YoY). Sales on the other hand came in at Rs 6 bn (up 5.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

PFIZER Announces Quarterly Results (1QFY21); Net Profit Up 10.3% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, PFIZER has posted a net profit of Rs 1 bn (up 10.3% YoY). Sales on the other hand came in at Rs 5 bn (down 5.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


May 12, 2021 (Close)

TRACK PFIZER

PFIZER - CIPLA COMPARISON

COMPARE PFIZER WITH

MARKET STATS